The Hindu Business Line
USFDA completes inspection at Natco’s API facility
Natco Pharma Ltd has announced the completion of a regulatory inspection from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) facility in Mekaguda Village near Hyderabad.
The inspection was conducted during August 5-9, and the facility received six observations mostly procedural in nature, the company said. It believes that none of observations are related to data integrity and that all the observations can be addressed within a short period of time.